Literature DB >> 7254233

Congenital myasthenia: end-plate acetylcholine receptors and electrophysiology in five cases.

A Vincent, S G Cull-Candy, J Newsom-Davis, A Trautmann, P C Molenaar, R L Polak.   

Abstract

The nature of the defect in congenital myasthenia was investigated in biopsy specimens of intercostal muscle from 5 male patients whose symptoms presented between birth and 2 years of age. Miniature end-plate potentials were reduced in amplitude in all 5 patients. The number of acetylcholine receptors as determined by alpha-bungarotoxin binding was normal in case 1 and reduced in cases, 2, 4, and 5. The shape of the end-plates as shown by autoradiography and cholinesterase staining was normal in case 1 and elongated in cases 2, 4, and 5. In cases 3, alpha-bungarotoxin binding was slowly reversible, and there were some muscle fibers with multiple end-plate regions. The acetylcholine content of the muscle was normal in all 5 cases. None of the patients had serum antibody to human acetylcholine receptor as measured by immunoprecipitation or inhibition of alpha-bungarotoxin binding. We conclude that congenital myasthenia is a heterogeneous condition of nonimmune etiology in which both presynaptic and postsynaptic defects can be found.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7254233     DOI: 10.1002/mus.880040407

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  10 in total

Review 1.  [Molecular pathogenesis of muscular diseases].

Authors:  K Ohlendieck
Journal:  Naturwissenschaften       Date:  1996-12

2.  Congenital myasthenic syndrome in the dog breed Gammel Dansk Hønsehund: clinical, electrophysiological, pharmacological and immunological comparison with acquired myasthenia gravis.

Authors:  A Flagstad; W Trojaborg; S Gammeltoft
Journal:  Acta Vet Scand       Date:  1989       Impact factor: 1.695

3.  Secondary changes of the motor endplate in Lambert-Eaton myasthenic syndrome: a quantitative study.

Authors:  L F Hesselmans; F G Jennekens; J Kartman; J H Wokke; M de Visser; E G Klaver-Krol; M DeBaets; F Spaans; H Veldman
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

4.  Hexosamine biosynthetic pathway mutations cause neuromuscular transmission defect.

Authors:  Jan Senderek; Juliane S Müller; Marina Dusl; Tim M Strom; Velina Guergueltcheva; Irmgard Diepolder; Steven H Laval; Susan Maxwell; Judy Cossins; Sabine Krause; Nuria Muelas; Juan J Vilchez; Jaume Colomer; Cecilia Jimenez Mallebrera; Andres Nascimento; Shahriar Nafissi; Ariana Kariminejad; Yalda Nilipour; Bita Bozorgmehr; Hossein Najmabadi; Carmelo Rodolico; Jörn P Sieb; Ortrud K Steinlein; Beate Schlotter; Benedikt Schoser; Janbernd Kirschner; Ralf Herrmann; Thomas Voit; Anders Oldfors; Christopher Lindbergh; Andoni Urtizberea; Maja von der Hagen; Angela Hübner; Jacqueline Palace; Kate Bushby; Volker Straub; David Beeson; Angela Abicht; Hanns Lochmüller
Journal:  Am J Hum Genet       Date:  2011-02-11       Impact factor: 11.025

5.  3,4-Diaminopyridine in the treatment of congenital (hereditary) myasthenia.

Authors:  J Palace; C M Wiles; J Newsom-Davis
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-12       Impact factor: 10.154

6.  Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays.

Authors:  A Vincent; J Newsom-Davis
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-12       Impact factor: 10.154

7.  Paucity of secondary synaptic clefts in a case of congenital myasthenia with multiple contractures: ultrastructural morphology of a developmental disorder.

Authors:  L M Smit; F G Jennekens; H Veldman; P G Barth
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-10       Impact factor: 10.154

Review 8.  The Structure of Human Neuromuscular Junctions: Some Unanswered Molecular Questions.

Authors:  Clarke R Slater
Journal:  Int J Mol Sci       Date:  2017-10-19       Impact factor: 5.923

9.  Salbutamol and ephedrine in the treatment of severe AChR deficiency syndromes.

Authors:  Pedro M Rodríguez Cruz; Jacqueline Palace; Hayley Ramjattan; Sandeep Jayawant; Stephanie A Robb; David Beeson
Journal:  Neurology       Date:  2015-09-22       Impact factor: 9.910

10.  Mutations in the Mitochondrial Citrate Carrier SLC25A1 are Associated with Impaired Neuromuscular Transmission.

Authors:  Amina Chaouch; Vito Porcelli; Daniel Cox; Shimon Edvardson; Pasquale Scarcia; Anna De Grassi; Ciro L Pierri; Judith Cossins; Steven H Laval; Helen Griffin; Juliane S Müller; Teresinha Evangelista; Ana Töpf; Angela Abicht; Angela Huebner; Maja von der Hagen; Kate Bushby; Volker Straub; Rita Horvath; Orly Elpeleg; Jacqueline Palace; Jan Senderek; David Beeson; Luigi Palmieri; Hanns Lochmüller
Journal:  J Neuromuscul Dis       Date:  2014
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.